DOHA: A researcher at Weill Cornell Medical College in Qatar (WCMC-Q) has contributed to a finding that could one day rival a drug commonly used for regulating cholesterol.
The discovery of how a form of microRNA helps control cholesterol could have huge implications, improving the quality of life and preventing premature deaths of tens of thousands of people every year. It is expected to rival statins as a means of regulating cholesterol.
Dr Hani Najafi, (pictured) Assistant Professor of Cell and Development Biology at WCMC-Q, and his fellow researchers at Massachusetts General Hospital and Harvard Medical School conducted the research which has been published in the Journal of Science Translational Medicine.
Dr Najafi said, “The work done so far has had very significant results and although we’re not yet at the stage of announcing a new drug, I am hopeful that the treatment will one day be clinically important.
“High cholesterol levels are associated with heart disease, diabetes and atherosclerosis — some of the main causes of premature death — and it would be very satisfying for myself, my team and WCMC-Q to think that we have helped prevent some of these deaths.”
Dr Najafi said the foundation of the research was established in 2010 when he found a novel mechanism that contributes to proper cholesterol/lipid levels in the human body.